Program and Abstracts of the 16th Transgenic Technology Meeting (TT2020)
- PDF / 1,725,801 Bytes
- 26 Pages / 547.087 x 737.008 pts Page_size
- 17 Downloads / 178 Views
(0123456789().,-volV) ( 01234567 89().,-volV)
ABSTRACTS
Program and Abstracts of the 16th Transgenic Technology Meeting (TT2020) Virtual meeting, October 26–29, 2020 Published online: 22 October 2020 Springer Nature Switzerland AG 2020
The TT2020 Meeting is hosted by The Weizmann Institute of Science, Israel
123
2
Transgenic Res (2020) 29:1–26
Committees Chair: Rebecca Haffner-Krausz, The Weizmann Institute, Israel Scientific Advisory Committee Wojtek Auerbach-President ISTT Karen B. Avraham Marina Gertenstein Rebecca Haffner Eran Hornstein Rodolf Jaenisch Lluis Montoliu Orly Reiner Janet Rossant Organizing Committee Jakub Abramson Wojtek Auerbach Karen B. Avraham Yossi Buganim Lynn Doglio Marina Gertenstein Alon Harmelin Peter Hohenstein Stefan Jung Noam Levaot Yonatan Stelzer Avraham Yaron ISTT Board of Directors
• Lectures, Awards • GEMM • IDT Integrated DNA Technologies • EMBO • GENOWAY • Regeneron • Janvier • Charles River Labs • Czech Centre for Phenogenomics Others Dimitris N. Chorafas Institute for Scientific Exchange Abraham Katzir Centre—Weizmann Institute of Science Kekst Family Institute for Medical Genetics The Department of Life Sciences Core Facilities—Weizmann Institute of Science Azrieli Institute for Systems Biology—Weizmann Institute of Science
TT2020 Scientific Program Monday, October 26th Time (Israel time) 15:00–15:15 15:15–16:30
Meeting Administration Inbal Azoulay
15:15–15:30
TT2020 Exhibitors/Sponsors
15:30–15:45
• • • • • • • • • • • • • • • • • • • • •
Gold Gempharmatech ISTT Sutter Instrument Sigma/Merck ParaTechs Corporation EPPENDORF Transnetyx Cergentis Cosmo Bio USA Silver Vectorbuilder The Company of Biologists Nepagene BEX UCDAVIS Synthego Ozgene Bronze WPI SCIONICS
123
15:45–16:00
16:00–16:15
16:15–16:30 16:30–16:45 16:45–18:20 16:45–17:20 17:20–17:35
Session/Lecture info Opening Address TT2020-Virtual Session 1: Panel Discussion—Animal Models: From Bench to Bedside (sponsored by GEMM-Genetic Engineered Mouse Models; National Israel Facility) Moderators, Karen Avraham, Jan Parker-Thornburg Paula Rio, CIEMAT, Spain Gene therapy for Fanconi anemia: From the lab to the clinic Eital Galun, The Hebrew University of Jerusalem, Israel Better Bedside-to-bench than Bench-tobedside, why? Aris Economides, Regeneron, USA Inhibition of Activin A by a monoclonal antibody as a diseasemodifying therapy for fibrodysplasia ossificans progressiva (FOP) Tom Wishart, Roslin Institute, UK How should we model neurodegenerative conditions? Using livestock to bridge the translational gap Discussion and Q&A Break Session 2: Epigenetics Chair: Janet Rossant Keynote: Howard Cedar, The Hebrew University of Jerusalem, Israel TBA Wei Li, Chinese Academy of Sciences, China Balancing embryonic development through ‘‘imbalance’’
Transgenic Res (2020) 29:1–26 17:35–17:50
17:50–18:05
18:05–18:20
18:20–18:35 18:35–19:20 18:35–18:45 18:45–19:20
19:20–20:20
Eran Meshorer, The Hebrew University of Jerusalem, Israel NFIX, which is differentially methylated between modern and archaic humans, reg
Data Loading...
